DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Traina TA, OʼShaughnessy J, Nanda R. et al.
Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR plus triple-negative breast cancer (TNBC).
Cancer Res 2015;
75: Abstract. P5-19-09
doi:10.1158/1538-7445.SABCS14-P5-19-09
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.